Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Service de Réanimation Médicale, CHRU de Besançon, Boulevard Fleming, 25030, Besançon, France.
Intensive Care Med. 2022 Apr;48(4):458-466. doi: 10.1007/s00134-022-06637-w. Epub 2022 Feb 22.
Acute mesenteric ischemia (AMI) is a rare, but life-threatening condition occurring among critically ill patients. Several factors have been associated with AMI, but the causal link is debated, most studies being retrospective. Among these factors, enteral nutrition (EN) could be associated with AMI, in particular among patients with shock. We aimed to study the factors independently associated with AMI in a post hoc analysis of the NUTRIREA-2 trial including 2410 critically ill ventilated patients with shock, randomly assigned to receive EN or parenteral nutrition (PN).
Post hoc analysis of the NUTRIREA-2 trial was conducted. Ventilated adults with shock were randomly assigned to receive EN or PN. AMI was assessed by computed tomography, endoscopy, or laparotomy. Factors associated with AMI were studied by univariate and multivariate analysis.
2410 patients from 44 French intensive care units (ICUs) were included in the study: 1202 patients in the enteral group and 1208 patients in the parenteral group. The median age was 67 [58-76] years, with 67% men, a SAPS II score of 59 [46-74], and a medical cause for ICU admission in 92.7%. AMI was diagnosed among 24 (1%) patients, mainly by computed tomography (79%) or endoscopy (38%). The mechanism of AMI was non-occlusive mesenteric ischemia (n = 12), occlusive (n = 4), and indeterminate (n = 8). The median duration between inclusion in the trial and AMI diagnosis was 4 [1-11] days. Patients with AMI were older, had a higher SAPS II score at ICU admission, had higher plasma lactate, creatinine, and ASAT concentrations and lower hemoglobin concentration, had more frequently EN, dobutamine, and CVVHDF at inclusion, developed more frequently bacteremia during ICU stay, and had higher 28-day and 90-day mortality rates compared with patients without AMI. By multivariate analysis, AMI was independently associated with EN, dobutamine use, SAPS II score ≥ 62 and hemoglobin concentration ≤ 10.9 g/dL.
Among critically ill ventilated patients with shock, EN, dobutamine use, SAPS II score ≥ 62 and hemoglobin ≤ 10.9 g/dL were independently associated with AMI. Among critically ill ventilated patients requiring vasopressors, EN should be delayed or introduced cautiously in case of low cardiac output requiring dobutamine and/or in case of multiple organ failure with high SAPS II score.
急性肠系膜缺血(AMI)是一种罕见但危及生命的疾病,发生在重症患者中。已有多种因素与 AMI 相关,但因果关系存在争议,大多数研究都是回顾性的。在这些因素中,肠内营养(EN)可能与 AMI 有关,特别是在休克患者中。我们旨在通过对包括 2410 例接受机械通气且伴有休克的重症患者的 NUTRIREA-2 试验进行事后分析,研究与 AMI 相关的独立因素,这些患者被随机分配接受 EN 或肠外营养(PN)。
对 NUTRIREA-2 试验进行事后分析。给予接受机械通气且伴有休克的成年患者 EN 或 PN。通过计算机断层扫描、内镜或剖腹术评估 AMI。通过单变量和多变量分析研究与 AMI 相关的因素。
来自 44 家法国重症监护病房(ICU)的 2410 例患者纳入了这项研究:1202 例患者进入肠内组,1208 例患者进入肠外组。中位年龄为 67 [58-76] 岁,67%为男性,急性生理与慢性健康评分 II(SAPS II)为 59 [46-74],入 ICU 的主要原因为内科疾病。24 例(1%)患者诊断为 AMI,主要通过计算机断层扫描(79%)或内镜(38%)诊断。AMI 的发病机制是非闭塞性肠系膜缺血(n=12)、闭塞性(n=4)和不明原因(n=8)。从纳入试验到 AMI 诊断的中位时间为 4 [1-11] 天。发生 AMI 的患者年龄更大,入 ICU 时 SAPS II 评分更高,血浆乳酸、肌酐和天门冬氨酸氨基转移酶浓度更高,血红蛋白浓度更低,EN、多巴酚丁胺和 CVVHDF 的使用率更高,ICU 期间更频繁地发生菌血症,28 天和 90 天死亡率更高。多变量分析显示,AMI 与 EN、多巴酚丁胺的使用、SAPS II 评分≥62 和血红蛋白浓度≤10.9 g/dL 独立相关。
在接受机械通气且伴有休克的重症患者中,EN、多巴酚丁胺的使用、SAPS II 评分≥62 和血红蛋白浓度≤10.9 g/dL 与 AMI 独立相关。在需要升压药物的接受机械通气且伴有休克的重症患者中,如果存在低心输出量需要多巴酚丁胺和/或存在高 SAPS II 评分的多器官衰竭,应延迟或谨慎开始 EN。